Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. - Wikidata - wikimedia - TriplyDB

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

http://www.wikidata.org/entity/Q36290630

about

Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells Sarcospan-deficient mice maintain normal muscle function Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy Filamin 2 (FLN2): A muscle-specific sarcoglycan interacting protein Different dystrophin-like complexes are expressed in neurons and glia Molecular organization of sarcoglycan complex in mouse myotubes in culture Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex Sarcoglycan isoforms in skeletal muscle Apoptosis repressor with a CARD domain (ARC) restrains Bax-mediated pathogenesis in dystrophic skeletal muscle Genome-wide association study identifies a novel locus contributing to type 2 diabetes susceptibility in Sikhs of Punjabi origin from India The Dystrophin Complex: Structure, Function, and Implications for Therapy SMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophy Biochemical and Functional Comparisons of mdx and Sgcg(-/-) Muscular Dystrophy Mouse Models.Myoferlin regulation by NFAT in muscle injury, regeneration and repair.Truncated dystrophins can influence neuromuscular synapse structure.β1-syntrophin modulation by miR-222 in mdx mice.Influence of immune responses in gene/stem cell therapies for muscular dystrophies.Control of muscle fibre size: a crucial factor in ageing.Plasma membrane cytoskeleton of muscle: a fine structural analysis.Sarcoglycans in muscular dystrophy.Restoration of gamma-sarcoglycan localization and mechanical signal transduction are independent in murine skeletal muscle.Diagnostic protein expression in human muscle biopsies.Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle.Mechanisms of muscle weakness in muscular dystrophy Role of nitric oxide in the pathogenesis of muscular dystrophies: a "two hit" hypothesis of the cause of muscle necrosis.Distinct genetic regions modify specific muscle groups in muscular dystrophy.Distinctive serum miRNA profile in mouse models of striated muscular pathologies.Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice.Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.Secondary coronary artery vasospasm promotes cardiomyopathy progression.Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex.Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.Muscle degeneration without mechanical injury in sarcoglycan deficiency Continuous myofiber remodeling in uninjured extraocular myofibers: myonuclear turnover and evidence for apoptosis.Cardiac function in muscular dystrophy associates with abdominal muscle pathology.Alpha7beta1 integrin does not alleviate disease in a mouse model of limb girdle muscular dystrophy type 2F Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects Contractile function, sarcolemma integrity, and the loss of dystrophin after skeletal muscle eccentric contraction-induced injury Effects of aging, exercise, and disease on force transfer in skeletal muscle.Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.

P2860

Q22253448-36F62F01-2AF5-411E-B614-9CCB41BEECF9 Q24554300-9430C953-368F-407B-8807-C3C085B63825 Q24604161-E22ECE25-E896-4148-95C0-94AAE677335B Q24632485-663F686A-3AB5-4C7C-AAAD-0F86D72D11C9 Q24684826-A4FCD713-2B4A-47B3-8445-784CF3E6AD65 Q24685886-3B4C89CC-9C71-4C91-922C-C9938A2F4503 Q28138974-233C4D3F-4F61-4048-9692-FDFCF640669D Q28141128-ACDA4AE1-4404-4DDC-89ED-D69E3B550755 Q28511114-0DA8570C-EFE5-4F51-99B7-959026FA98B5 Q29417002-B4F9EF2E-5576-4861-8A1F-0C00DEC1F248 Q30376293-31898FD9-9A90-4D1F-BE21-A0945F7D18EC Q30498086-871157A6-4FD4-4677-B215-F1B009CF90C8 Q30650746-73128DBE-BCC6-4EEB-8529-1A0FE7AB9DB3 Q33613460-90967B74-A9C4-4A4B-A50E-3F2AF273166E Q33676836-096F5407-6305-436E-A490-D316CB99D2B7 Q33697991-7EB9E3EB-D55E-43EC-9EBC-E4E4A5B5FB30 Q33736192-B112DBDE-BEDA-4EF6-A65F-E813FE6EB4AA Q33815693-1C0439BD-C01B-4CBD-9EDD-33A7195301EE Q33840927-19520298-E909-4F59-A6E5-874FF39E4E40 Q33840940-A0F2EA9D-9649-469D-B42C-EA0F6C61AD64 Q33883334-F971C70F-1705-4FF1-AD6D-43CF7AE73E68 Q33891334-9474C8F5-6294-464D-B927-A93C2EED597C Q33893451-FD5F30E1-1F70-46FD-A598-26B3CBC6F566 Q33950716-2E76C124-7BED-477A-ADA3-B0ADFBF3F73C Q34465820-BC418353-7530-4CF4-9C90-5A78247E401D Q34518008-D2590A16-F231-4C1B-9F3E-255DDD41165B Q34589538-E6853A0B-07F5-4C72-9D59-ADEFA869D03E Q34627033-4E65A280-BA13-4306-85C3-EA7512E40C32 Q34654773-30AB831F-2C7D-496E-B59B-61AB0FB335D0 Q35096094-8E101BDD-3E32-45B4-A81E-B15C029525FF Q35169510-DB0FFEA6-DC1F-4EFD-B926-1F3DA0066D95 Q35253089-FE229897-0821-4BFB-BDCB-0914EB080BA3 Q35630800-9BE2FC70-54AF-49B4-AC14-8037ED827865 Q35633086-5D23CAEF-667E-463F-A203-93ED25C7CFA7 Q35660390-06814F33-EEA2-47E0-BD18-A64E18E0DA11 Q35750080-3FBEE182-94BF-46CC-A29A-E29F90A26D8C Q35758335-0B8D9A58-9551-4EAA-8686-3F7F26B190B7 Q35811023-DDC609BB-9AE5-4EC0-A3D0-99E7DE970A5E Q35813381-CE29387D-D928-4362-9663-47139CD6DBD4 Q35924068-BB259B0A-87C4-4F0E-B85F-1614A7E69D31

P2860

Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin.

http://www.wikidata.org/entity/Q36290630

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh

1998年學術文章

@zh-hant

name

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@ast

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@en

type

label

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@ast

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@en

prefLabel

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@ast

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@en

P1433

Q36290630-AC23F54F-02D0-4918-A5FF-40C32EB0E6F8

P1476

Q36290630-FFBA537A-FD67-4D32-A4C6-2CF8A3968941

P2093

Q36290630-094D5DDD-689C-47E6-BB7B-C70EEFCC6D49

Q36290630-25E69500-EC2E-4B77-8737-DB7FD6AAED4C

Q36290630-440F68F6-04C5-49CB-9C9A-6F4D6812E854

Q36290630-502762A4-9F4B-44CA-8002-BC3628AA965F

Q36290630-63904CF3-AA4F-4BED-B1B3-CDA28FC7F35F

Q36290630-A1B434B0-6B0D-47B7-B201-3D6A93D9A955

Q36290630-A505400C-FD3B-4A81-8AAC-8842A8A8E3F3

P2860

Q36290630-0415061F-0242-4A9E-855C-B4AA7AF36591

Q36290630-0B5F7707-244C-4300-A063-EA8872B495B3

Q36290630-0B8C8535-0AA3-47A5-AC1C-2EACF2503262

Q36290630-0C244395-25E0-47BF-9846-59306688A448

Q36290630-0C627ED7-6F5E-462E-A433-823D56505DA9

Q36290630-1756004D-8A26-4F69-A1C1-A372F6DE81BE

Q36290630-2080ECED-FEE9-4E5E-ABA6-022F5918C8A6

Q36290630-2145F332-18ED-4B23-A7C8-FAABD8467200

Q36290630-2BA75AC1-189F-4F86-A582-068D0B73E5B1

Q36290630-2F08E7EA-3FB2-4637-B7AD-BAB58A575BE8

P304

Q36290630-5302E81B-92A2-4666-BC28-D45426610F8D

P31

Q36290630-098B8BE3-14E0-4843-A712-C317AAE2E9E2

P356

Q36290630-FDD51B0C-18D4-4134-8298-0BF4DF22C2A1

P407

Q36290630-E135FBD3-3F7D-4D03-A224-656E7D595658

P433

Q36290630-5F05EEC5-12E4-4360-BFB8-2835133577EC

P478

Q36290630-2D90B2A4-1790-47C9-B3D7-02BF079F040C

P577

Q36290630-376538A2-E82A-41AA-8EC2-C71E3913987F

P5875

Q36290630-8F05ABCA-EA3E-4C75-A036-9BC0C7D7CD29

P698

Q36290630-0C09F0D7-676A-4C75-AFF4-8D8009AAE410

P921

Q36290630-01B7876B-30FC-41A8-9342-F8002EA124A2

P932

Q36290630-C4E435F2-8F7D-48C0-ABD0-5A6FCA002C1C

P356

P1433

Journal of Cell Biology

P1476

Gamma-sarcoglycan deficiency l ...... sis independent of dystrophin.

@en

P2093

A A Hack

http://www.w3.org/2001/XMLSchema#string

C J Clendenin

http://www.w3.org/2001/XMLSchema#string

C T Ly

http://www.w3.org/2001/XMLSchema#string

E M McNally

http://www.w3.org/2001/XMLSchema#string

F Jiang

http://www.w3.org/2001/XMLSchema#string

K S Sigrist

http://www.w3.org/2001/XMLSchema#string

R L Wollmann

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

Human epsilon-sarcoglycan is highly related to alpha-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene

Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein

Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12

epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D

Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E)

Dystroglycan is a binding protein of laminin and merosin in peripheral nerve

An autosomal transcript in skeletal muscle with homology to dystrophin

Primary structure and muscle-specific expression of the 50-kDa dystrophin-associated glycoprotein (adhalin)

P304

1279-1287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.142.5.1279

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

142

http://www.w3.org/2001/XMLSchema#string

P577

1998-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236240836

http://www.w3.org/2001/XMLSchema#string

P698

9732288

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

2149352

http://www.w3.org/2001/XMLSchema#string